How to Sell Your DME (Durable Medical Equipment) Business in 2026
DME businesses are selling at 3.0 to 5.0 times their annual profit, with recurring rental and resupply revenue driving the premium. If you are considering a DME business exit, this guide covers what your company is worth, who is buying, how deals get structured, and how to sell without your staff or referral sources finding out.
2026 DME Market Snapshot
3.0x - 5.0x
Profit Multiple (SDE)
4.0x
Average Multiple
6-10 mo
Time to Close
Strong
Buyer Demand
Why 2026 Is an Active Market for DME
Demographics keep pushing demand. Roughly 10,000 Americans turn 65 every day, and the shift toward aging in place means more oxygen, mobility, sleep, and home safety equipment moving through home-based channels every year.
Private equity has been consolidating the HME/DME space for years and still needs acquisitions to grow. Platforms that bought their anchor companies now buy independents like yours to add territories, referral relationships, and product lines.
Recurring revenue is in fashion. Buyers across every industry pay premiums for predictable revenue, and DME rental fleets plus CPAP resupply programs are exactly that. Sleep and respiratory books of business are among the most sought-after assets in healthcare services.
Reimbursement has been comparatively stable. Medicare competitive bidding has sat in a gap period for most product categories, which has taken the biggest pricing shock off the table and made cash flows easier for buyers to underwrite.
Independents face rising complexity. Payer audits, prior authorization requirements, and billing technology costs keep climbing, which pushes some owners to exit and makes well-run independents more valuable to acquirers who already have that infrastructure.
How DME Businesses Are Valued
Most DME businesses are valued on Seller's Discretionary Earnings (SDE): your profit plus your salary and personal expenses running through the business. A buyer multiplies your SDE by a number (the "multiple") to get your business value. Companies with over $1,000,000 in EBITDA typically trade on EBITDA multiples instead, often 4.0x to 6.0x.
Recurring revenue is the foundation of a DME valuation. Capped rental income and resupply programs get valued like subscriptions. One-time equipment sales get valued like retail. The same dollar of profit is worth more when it repeats every month.
Billing quality is inspected line by line. Buyers look at denial rates, days sales outstanding, and audit history because in DME, revenue on paper is not revenue until the claim is paid.
Compliance carries real weight. Current accreditation, clean payer audits, complete medical necessity documentation, and an active surety bond are table stakes. Gaps here do not just lower the price, they can end the deal.
The Four Drivers That Move Your Multiple
Two DME companies with identical profit can sell for wildly different prices. These four factors explain most of the gap. For a deeper breakdown with worked examples, see our DME business valuation guide.
1. Medicare Accreditation and Billing Infrastructure
Buyers verify your DMEPOS accreditation (ACHC, CHAP, The Joint Commission, or another CMS-approved body), your compliance with the Medicare supplier standards, and your surety bond before they look at anything else. A company with current accreditation, a documented compliance program, and a clean history with payer audits is a turnkey acquisition. A company with lapsed accreditation or open audit findings is a project, and buyers price projects accordingly. Strong billing operations, meaning low denial rates, tight prior authorization workflows, and receivables collected inside 60 days, can add half a turn to your multiple on their own.
2. Payer Mix
A balanced book across Medicare, commercial insurance, and cash retail is the ideal. Heavy dependence on a single payer, especially Medicaid in states with thin reimbursement, compresses the multiple because one fee schedule change can reshape your economics overnight. Cash and retail revenue (home accessibility, compression, bracing, retail CPAP supplies) is increasingly prized because it carries no audit risk and no reimbursement exposure. If you can show a payer mix where no single program drives more than half of revenue, you remove one of the buyer's biggest discount arguments.
3. Referral Concentration
Buyers will map exactly where your orders come from: physician practices, hospital discharge planners, sleep labs, wound care clinics, home health agencies. If any single referral source drives more than 20-25% of revenue, expect the offer to reflect that risk, often with part of the price held back in an earnout tied to referral retention. Diversified referrals across many prescribers, plus documented relationships that belong to the company rather than to you personally, protect your price. If your top three referral sources would keep sending orders after you leave, you have something buyers pay up for.
4. Product Mix: Rental vs Sale
This is the driver most owners underestimate. Rental revenue (oxygen concentrators, hospital beds, wheelchairs, and other capped rental items) repeats every month, and resupply programs (CPAP masks, tubing, filters, ostomy and urology supplies) repeat on a predictable schedule. Buyers can model that revenue years forward, so they pay subscription-style multiples for it. One-time equipment sales, by contrast, restart at zero every month. A DME business with 60% or more of revenue from rentals and resupply typically sells for a full turn higher than a comparable business built on one-time sales. If your resupply compliance rates are strong, document them, they are a selling point.
What Affects Your DME Value?
What Makes a DME Business Valuable
- High recurring revenue share, Rental fleets and resupply programs that generate 60%+ of revenue are the strongest signal a buyer can see. Predictable revenue earns premium multiples.
- Current accreditation and clean audits, Active DMEPOS accreditation, a documented compliance program, and no open payer audits or recoupments make the deal financeable and fast.
- Balanced payer mix, Medicare, commercial, and cash retail in healthy proportions. No single payer over half of revenue.
- Diversified referral base, Orders from many prescribers and facilities, with no single source above 20-25% of revenue, and relationships that survive your departure.
- Clean receivables, Days sales outstanding under 60, low denial rates, and minimal AR past 120 days show the billing engine actually works.
- A team that runs without you, A billing lead, a respiratory therapist or fitter where required, and delivery technicians who stay post-sale. Owner-dependence is a discount everywhere, and DME is no exception.
What Brings Your Value Down
- Open payer audits, recoupment demands, or unresolved overpayment notices
- Medical necessity documentation gaps: missing orders, expired prior authorizations, incomplete proof of delivery
- One referral source or one payer driving 40%+ of revenue
- Aging receivables, especially AR over 120 days that will never be collected
- Lapsed or soon-to-expire accreditation, state licenses, or surety bond
- Declining resupply compliance rates or a shrinking rental fleet
- Inventory records that do not match physical stock, including rental assets in patient homes with no tracking
- Revenue billed under a different legal entity than the one being sold
Wondering how much your DME business is worth?
Our free calculator factors in your revenue mix, payer mix, margins, and growth. Takes about 5 minutes, and requesting the full report locks in a $1,000 exit credit toward your success fee if BridgeBook sells your business.
Who Is Buying DME Businesses?
Four main buyer types, listed by who typically pays the highest multiples:
PE-Backed HME Platforms
4-6x SDE and higher for standout companies. Private equity groups building regional and national HME platforms buy independents to add territories, referral networks, and resupply books. Best fit for companies with $500,000+ in SDE and strong recurring revenue.
Regional DME/HME Operators
3.5-5x SDE. Existing operators expanding into your service area or adding a product line (sleep, mobility, respiratory) they do not carry. They understand accreditation and payer enrollment, so they close efficiently.
Adjacent Healthcare Companies
3.5-5x SDE. Home health agencies, infusion companies, pharmacies, and medical supply distributors adding DME to their continuum. They value your referral relationships and payer contracts, and may pay a premium for geographic fit.
Owner-Operators
3-4x SDE. Healthcare professionals and searchers buying their first company, usually with SBA financing. Straightforward deals, but the buyer's need for new payer enrollment in an asset sale requires careful transition planning.
What Every Buyer Looks For
Across all four buyer types, diligence in DME converges on the same questions. Can the revenue be verified claim by claim? Will the referral sources keep ordering after the owner leaves? Is the billing compliant enough to survive an audit? And how much of the revenue repeats without new sales effort? If you can answer all four with documentation instead of assurances, you are in the top tier of sellable DME companies.
Not sure which buyer type fits your company? Book a free 45-minute call, we will match you based on your size, product mix, and goals. Booking and attending locks in a $2,500 exit credit toward the success fee if BridgeBook sells your business.
How DME Deals Get Structured
Structure matters more in DME than in most industries because your Medicare supplier number, accreditation, and payer contracts do not automatically follow the assets. Here is what to expect:
Asset Sale vs Stock Sale
In most small-business sales, buyers strongly prefer asset purchases for tax and liability reasons. DME is the big exception. In an asset sale, the buyer generally needs its own Medicare enrollment (a new PTAN), its own accreditation, and new payer contracts, which can take months and create a billing gap. In a stock sale, the legal entity survives, so the supplier number, accreditation, and contracts typically remain in place through a change of ownership filing.
Because of this, DME deals are structured as stock sales far more often than deals in other industries, sometimes with indemnities and escrows to protect the buyer from pre-close billing liabilities. If your buyer insists on an asset sale, plan the enrollment timeline early: the gap between closing and the buyer's first paid claim is a real negotiating issue. Your healthcare attorney and your accountant should both weigh in before you sign a letter of intent.
SBA Financing
DME businesses with clean books and verifiable cash flow are generally good candidates for SBA 7(a) acquisition loans, which fund deals up to $5,000,000. That matters for you as a seller because SBA financing dramatically widens your buyer pool: an individual buyer with $150,000 down can credibly purchase a $1,500,000 company. Lenders will scrutinize your payer audit history and revenue concentration, which is one more reason to clean those up before going to market.
Seller Notes and Earnouts
Expect some portion of the price to be deferred. A seller note of 10-20% of the purchase price is common, and it signals to the buyer and their lender that you believe in the business you are selling. In SBA deals, part of the note is often placed on standby. Earnouts show up when a buyer worries about referral retention: a slice of the price is paid only if revenue from key referral sources holds for 12-24 months after closing. Earnouts are negotiable, and the best defense against a big one is the referral diversification you built before listing. Our DME preparation guide covers how to shore this up 6-12 months ahead of a sale.
What It Costs to Sell with BridgeBook
BridgeBook is founder-led by Legend Atty and works on a success fee only: no retainers, no upfront costs, no monthly fees. The fee is tiered, starting at 10% on the first $1,000,000 of the sale price and sliding down to 3% above $7,000,000.
You can also reduce that fee before you ever list. Booking and attending a free 45-minute consultation locks in a $2,500 exit credit, and requesting the free valuation report adds another $1,000, for $3,500 total, applied when BridgeBook sells your business.
How to Sell Your DME Business (Step by Step)
1. Get a Valuation
Start with our free valuation calculator. It takes about 5 minutes and gives you a range based on your revenue, profit, recurring revenue share, and payer mix. Knowing your number first keeps you from anchoring to a lowball unsolicited offer, which many DME owners receive from consolidators every year.
2. Assemble Your Team
You will need an M&A advisor or DME business broker experienced in healthcare deals, a healthcare attorney for the purchase agreement and the change of ownership or enrollment filings, and your accountant to prepare clean financials and model the tax difference between an asset and stock sale. DME deals fail on regulatory details more than on price, so do not go to market without advisors who have seen these deals before.
3. Prepare Your Documentation
Buyers will ask for:
- 24-36 months of profit & loss statements (monthly), plus balance sheets
- Revenue broken out by product category and by rental vs sale vs resupply
- Payer mix report and fee schedules for your top payers
- Referral source report showing where orders originate and any concentration
- Accreditation certificates, state licenses, surety bond, and Medicare enrollment records
- Audit history: any TPE, RAC, UPIC, or commercial payer audits and their outcomes
- AR aging report and denial rate data from your billing system
- Rental fleet and inventory records, including assets in patient homes
- Staff roster with roles, credentials, tenure, and compensation
4. Optimize Before You List
In the 6-12 months before you sell, focus on growing resupply enrollment, collecting old AR, renewing accreditation and licenses so nothing expires mid-deal, and spreading referral relationships across your team. Every improvement here shows up as a higher multiple at closing. The full checklist is in our DME business preparation guide.
5. Go to Market Under NDA
Your advisor lists the business confidentially with a blind profile: buyers see the financial picture and the opportunity, not your company name, location, or referral relationships. On BridgeBook's NDA-gated marketplace, buyers must sign an NDA and verify themselves before they can access identifying details. This matters enormously in DME: if referral sources or competitors learn you are selling before the deal is done, orders can quietly shift elsewhere. Serious buyers review your information and submit a letter of intent (LOI) with price and structure.
6. Due Diligence and Close
Once you accept an LOI, the buyer verifies everything: billing samples against medical necessity documentation, payer contracts, accreditation status, rental fleet counts, referral source data, and employment agreements. Expect 60-120 days of diligence for a DME deal, longer if the structure requires new payer enrollment.
Then the regulatory work closes out: change of ownership filings or new enrollment, state license transfers, and payer notifications. Most sellers provide 60-90 days of transition support, and buyers often ask the owner to personally introduce them to top referral sources during that window. For a broader walkthrough of the sale process in any industry, see our guide on how to sell a business.
Common Deal-Killers in DME Sales
Most failed DME deals die in diligence, not at the negotiating table. These are the issues that most often end a deal after the LOI:
Billing that cannot be verified
The buyer samples claims and finds missing physician orders, expired prior authorizations, or proof of delivery gaps. In DME, documentation problems read as recoupment risk, and buyers walk.
An undisclosed audit or recoupment
A TPE or UPIC audit that surfaces mid-diligence is far worse than one disclosed upfront with a clean resolution. Disclose early, with context.
Referral concentration discovered late
The blind profile said "diversified referrals" but diligence shows one sleep lab driving 45% of orders. Now the price gets rebuilt around an earnout, and trust is damaged.
Accreditation or license expiring mid-deal
A lapse during diligence can pause billing and spook lenders. Renew everything before you list, even if renewal seems early.
AR that overstates the business
If a large slice of receivables is over 120 days old, buyers treat it as worthless and reprice. Collect or write off old AR before going to market.
Owner-held relationships with no transition plan
If every referral source knows only you, buyers fear the revenue leaves with you. A named second contact for each key account defuses this.
Timeline: What to Expect
A typical DME business exit runs 6 to 10 months from listing to close. Here is how the time usually breaks down:
Preparation
Valuation, financial cleanup, documentation gathering, and fixing the issues buyers will find anyway. Time spent here shortens everything that follows.
Confidential marketing
Blind profile goes live, NDAs get signed, qualified buyers review the data, and offers come in. Strong recurring-revenue companies often collect multiple LOIs in this window.
LOI to close
Due diligence, purchase agreement negotiation, financing approval, and the regulatory filings: change of ownership or new enrollment, license transfers, and payer notifications. Stock sales usually run faster here than asset sales.
Two structural choices affect the clock more than anything else. First, deal structure: an asset sale that requires the buyer to obtain new Medicare enrollment and accreditation can add 60-90 days versus a stock sale. Second, preparation: sellers who show up with organized financials, current accreditation, and a clean audit file consistently close months faster than sellers who assemble documents on demand.
Frequently Asked Questions
How much is my DME business worth?
Most DME businesses sell for 3.0 to 5.0 times their annual profit (SDE). Companies with recurring rental and resupply revenue, current Medicare accreditation, a balanced payer mix, and diversified referral sources command the top of the range. Larger DME companies with over $1,000,000 in EBITDA typically trade on EBITDA multiples instead, often 4.0x to 6.0x. Use our free valuation calculator for a personalized estimate.
Will my Medicare supplier number transfer to the buyer?
It depends on the deal structure. In a stock sale, the legal entity survives, so the Medicare supplier number (PTAN), accreditation, and payer contracts typically stay in place through a change of ownership filing. In an asset sale, the buyer usually needs its own enrollment and accreditation, which can create a billing gap if not planned early. This is why DME deals are structured as stock sales more often than deals in most other industries.
How long does it take to sell a DME business?
Typically 6 to 10 months from listing to close. Payer enrollment, accreditation transfer, and state licensing are the usual sources of delay, especially in asset sales where the buyer must re-enroll with Medicare. Well-documented companies with clean billing audits and a stock-sale structure close faster.
Does rental and resupply revenue really increase my multiple?
Yes. Recurring revenue from capped rentals (oxygen concentrators, hospital beds, wheelchairs) and resupply programs (CPAP masks, tubing, filters) is the single biggest multiple driver in DME. Buyers pay a premium for revenue they can forecast. A DME business with 60% or more recurring revenue typically sells for a full turn higher than a comparable business built on one-time equipment sales.
Do I need a DME business broker, and can I sell confidentially?
You can sell on your own, but DME deals involve payer enrollment, accreditation transfer, billing compliance diligence, and buyer vetting that most owners have never navigated. A broker who understands healthcare deals runs the process confidentially: your company name, location, and referral relationships stay hidden behind a blind profile until a buyer signs an NDA and shows proof of funds. BridgeBook works on a success fee only, with no retainers, so you pay nothing unless your business sells.
What Is Your DME Business Worth?
Free. Confidential. Takes about 5 minutes. And if BridgeBook sells your business, the valuation report and a strategy call lock in $3,500 in exit credits toward the success fee.